|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-10-16
|
|
pubmed:abstractText |
Livedo vasculitis is thought to be a thrombogenic disorder. We demonstrated that thrombomodulin (TM) expression on the endothelial cells in livedo vasculitis was markedly reduced, while blood tests of coagulation and fibrinolytic activities were within the normal range.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1018-8665
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
192
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
120-4
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8829492-Adolescent,
pubmed-meshheading:8829492-Adult,
pubmed-meshheading:8829492-Aged,
pubmed-meshheading:8829492-Aspirin,
pubmed-meshheading:8829492-Child,
pubmed-meshheading:8829492-Drug Therapy, Combination,
pubmed-meshheading:8829492-Epidermis,
pubmed-meshheading:8829492-Epoprostenol,
pubmed-meshheading:8829492-Female,
pubmed-meshheading:8829492-Humans,
pubmed-meshheading:8829492-Leg Ulcer,
pubmed-meshheading:8829492-Middle Aged,
pubmed-meshheading:8829492-Platelet Aggregation Inhibitors,
pubmed-meshheading:8829492-Thrombomodulin,
pubmed-meshheading:8829492-Treatment Outcome,
pubmed-meshheading:8829492-Up-Regulation,
pubmed-meshheading:8829492-Vasculitis
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation.
|
|
pubmed:affiliation |
Department of Dermatology, Kanazawa University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
